Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)

Metastatic non-small cell lung cancer (NSCLC) unfortunately remains a lethal disease, despite recent genetic characterization of subclasses of NSCLC, mainly adenocarcinoma, which has led to the development of targeted therapies that improve progression-free survival (PFS). Ultimately, however, patie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Lung Cancer Res
Egile Nagusiak: Wei, Jia, Moran, Teresa, Zou, Zhengyun, Qian, Xiaoping, Wang, Lifeng, Camps, Carlos, Hu, Wenjing, Chaib, Imane, Sanchez, Belén, Xu, Lixia, Karachaliou, Niki, Sanchez-Ronco, María, Liu, Baorui, Rosell, Rafael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2013
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367603/
https://ncbi.nlm.nih.gov/pubmed/25806231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.02.03
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak